Testing effectiveness (Phase 2)Looking for participantsNCT07076212
What this trial is testing
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
Medical University of South Carolina 52